Document Number
REG-003
Version
v1.0
Classification
CONTROLLED DOCUMENT
Effective Date
May 7, 2026
Author
Regulatory Affairs
Owner
Regulatory Affairs
ISO Clause
N/A
Tier Level
Tier 2 — SOP/Plan
FDA 510(k) Indications for Use statement for the Osteofy BMD Analysis System.
#fda#510k#indications-for-use#ifu
Approval Status
DraftEffective: May 7, 2026
Regulatory Standards
21 CFR Part 820
Revision History
| Version | Date | Author | Description |
|---|---|---|---|
| v1.0 | May 7, 2026 | Regulatory Affairs | Initial release |